Navigating the intricate landscape of legal acquisition for controlled substances, specifically Schedule I drugs, represents a particularly specialized area for licensed national institutions—typically research facilities—and demands meticulous adherence to stringent regulations. The process goes far beyond standard provider selection, encompas… Read More